Hepatitis E virus infection in the Irish blood donor population

Transfusion

Volumn 56, Issue 11, 2016, Pages 2868-2876

  O'Riordan, Joan ^a   Boland, Fiona ^a   Williams, Padraig ^a   Donnellan, Joe ^a   Hogema, Boris M ^b   Ijaz, Samreen ^c   Murphy, William G ^a  

^a National Blood Centre Ireland   (Ireland)

^b SANQUIN RESEARCH   (Netherlands)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INCIDENCE; IRISH (CITIZEN); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS LOAD; ADOLESCENT; BLOOD; GENETICS; IRELAND; SEROEPIDEMIOLOGY; VIREMIA; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD DONORS; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; IRELAND; MIDDLE AGED; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 84981313404     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13757     Document Type: Article

References (44)

1. Legrand-Abravanel F, Mansuy JM, Dubois M, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009;15:110–4.
2. Dalton HR, Hazeldine S, Banks M, et al. Locally acquired hepatitis E in chronic liver disease. Lancet 2007;369:1260.
3. Péron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007;14:298–303.
4. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481–9.
5. Versluis J, Pas SD, Agteresch HJ, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013;122:1079–86.
6. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025–7.
7. Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang 2016;110:93–103.
8. Hogema BM, Molier M, Sjerps M, et al. Incidence and duration of hepatitis E virus infection in Dutch blood donors. Transfusion 2016;56:722–8.
9. Slot E, Hogema BM, Riezebos-Brilman A, et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18. pii: 20550.
10. Cleland A, Smith L, Crossan C, et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283–9.
11. Dalton HR, Saunders M, Woolson KL. Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history? J Virus Erad 2015;1:23–9.
12. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766–73.
13. Assal A, Piquet Y, Gallian P, et al. Transfusion transmission of hepatitis E virus by solvent-detergent inactivated plasma. Transfusion 2013;214–5A.
14. Human plasma (pooled and treated for virus inactivation), monograph 1646. Ph. Eur. 8th ed. Strasbourg, France: Council of Europe; 2015.
15. Hauser L, Roque-Afonso AM, Beylouné A, et al. Hepatitis E transmission by blood transfusion on Intercept blood-treated plasma. Blood 2014;123:796–7.
16. Bendall R, Ellis V, Ijaz S, et al. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008;80:95–101.
17. Sauleda S, Ong E, Bes M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55:972–9.
18. Wang Y, Ling R, Erker JC, et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol 1999;80:169–77.
19. Ijaz S, Arnold E, Banks M, et al. Non travel-associated hepatitis E in England and Wales: demographic, clinical and molecular epidemiological characteristics. J Infect Dis 2005;192:1166–72.
20. Ijaz S, Said B, Boxall E, et al. Indigenous hepatitis E in England and Wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 2014;209:1212–8.
21. Smith DB, Ijaz S, Tedder RS, et al. Variability and pathogenicity of hepatitis E virus genotype 3 variants. J Gen Virol 2015;96:3255–64.
22. Baylis SA, Hanschmann KM, Blümel J, et al. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011;49:1234–9.
23. Shrestha AC, Seed CR, Flower RLP, et al. Hepatitis E virus and implications for blood supply safety, Australia. Emerg Infect Dis 2014;20:1940–2.
24. Beale MA, Tettmar K, Szypulska R, et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011;100:340–2.
25. Holm DK, Moessner BK, Engle RE, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662–7.
26. Xu C, Wang RY, Schechterly CA, et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013;53:2505–11.
27. Gallian P, Lhomme S, Piquet Y, et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 2014;20:1914–7.
28. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309–12.
29. Pas SD, Streefkerk RH, Pronk M, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013;58:629–34.
30. Stramer SL, Moritz ED, Foster GA, et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56:481–8.
31. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026–31.
32. Ijaz S, Vyse AJ, Morgan D, et al. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009;44:272–6.
33. Hogema BM, Molier M, Slot E, et al. Past and present of hepatitis E in the Netherlands. Transfusion 2014;54:3092–6.
34. Grierson S, Heaney J, Cheney T, et al. Prevalence of hepatitis E virus infection in pigs at the time of slaughter, United Kingdom, 2013. Emerg Infect Dis 2015;21:1396–401.
35. Berto A, Martelli F, Grierson S, et al. Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerg Infect Dis 2012;18:1358–60.
36. Said B, Ijaz S, Chand MA, et al. Hepatitis E virus in England and Wales: indigenous infection is associated with the consumption of processed pork products. Epidemiol Infect 2014;142:1467–75.
37. O'Connor M, Roche SJ, Sammin D. Seroprevalence of hepatitis E virus infection in the Irish pig population. Ir Vet J 2015;68:8.
38. Huzly D, Umhau M, Bettinger D, et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014;19. pii: 20812.
39. Charlton A, Wallis J, Robertson J, et al. Where did platelets go in 2012? A survey of platelet transfusion practice in the North of England. Transfus Med 2014;24:213–8.
40. Tinegate H, Pendry K, Murphy M, et al. Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014. Transfusion 2016;56:139–45.
41. Fontana RJ, Engle RE, Trivedi S, et al. The role of hepatitis E virus infection in adult American patients with acute liver failure. Hepatology 2012;56:958A–9A.
42. Samala N, Wright EC, Buckler G, et al. Hepatitis E virus does not contribute to hepatic decompensation among patients with advanced chronic hepatitis C. Clin Gastroenterol Hepatol 2016;14:896–902.
43. Manka P, Bechmann LP, Coombes JD, et al. Hepatitis E virus infection as a possible cause of acute liver failure in Europe. Clin Gastroenterol Hepatol 2015;13:1836–42.
44. Serious Hazards of Transfusion SHOT Steering Group. Annual SHOT Report 2014 [Internet]. Manchester: SHOT Office; 2015 [cited 2014 Sep 24]. Available from: http://www.shotuk.org/wp-content/uploads/report-2014.pdf.